Cambridge scientists have identified a signature in the blood that could help predict how well an individual will respond to vaccines. ̽»¨Ö±²¥discovery, published today in Nature Communications, may explain why, even among vulnerable patient groups, some individuals have better responses to vaccines than others.
Cambridge scientists have used synthetic biology to create artificial enzymes programmed to target the genetic code of SARS-CoV-2 and destroy the virus, an approach that could be used to develop a new generation of antiviral drugs.
An estimated 7,000 students are already taking part each week in the ̽»¨Ö±²¥ of Cambridge’s Asymptomatic COVID-19 Screening Programme, but the team running the programme are encouraging as many students as possible to join in, and help keep Cambridge safe.
When Addenbrooke’s Hospital in Cambridge upgraded its face masks for staff working on COVID-19 wards to filtering face piece 3 (FFP3) respirators, it saw a dramatic fall – up to 100% – in hospital-acquired SARS-CoV-2 infections among these staff.
A combination of testing programmes for staff and students, infection control measures and genomic surveillance helped reduce the number of cases of COVID-19 at the ̽»¨Ö±²¥ and keep the wider community safe.
Since the start of October, a dedicated team drawn from across the ̽»¨Ö±²¥ and its Colleges has been running an innovate programme to screen its students for COVID-19. Getting it up and running in time may have been a Herculean task, but its success has been remarkable.
̽»¨Ö±²¥drug remdesivir is likely to be a highly effective antiviral against SARS-CoV-2, according to a new study by a team of UK scientists. Writing in Nature Communications, the researchers describe giving the drug to a patient with COVID-19 and a rare immune disorder, and observing a dramatic improvement in his symptoms and the disappearance of the virus.
Governments and health agencies should reconsider the current guidelines with regards to widespread mask use in the COVID-19 pandemic and recommend that masks be worn by everyone, argue a team of researchers at the ̽»¨Ö±²¥ of Cambridge
© 2025 ̽»¨Ö±²¥ of Cambridge